Financials

  • Market Capitalization 9.85 B
  • Employee 7 450
  • Founded N/A
  • CEO Norman David Schwartz
  • Website www.bio-rad.com
  • Headquarter Delaware, United States
  • FIGI BBG000DY28W5
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
7133
MDAIW
Spectral AI Inc - Warrants
0.3306 USD-4.23%-24.86%-26.53%-35.18%41.84 M USD
7214
HSCSW
HeartSciences Inc - Warrant
0.0670 USD-40.75%-31.91%-16.04%+3.08%10.22 M USD
7244
BDMDW
Baird Medical Investment Holdings Ltd - Warrant
0.0189 USD-44.44%+36.96%-37.42%-62.28%3.69 M USD
7269
TNONW
Tenon Medical Inc - Warrant
0.0037 USD-2.63%-17.78%-21.28%-66.36%940.54 K USD

Frequently asked questions about Bio-Rad Laboratories, Inc.Class A

What is the Bio-Rad Laboratories, Inc.Class A stock price today?

The current price of Bio-Rad Laboratories, Inc.Class A (BIO-B) is 364.15. Over the past 24 hours, the stock has changed by 0.00%. Follow the BIO-B chart for real-time price dynamics.

What is the stock ticker of Bio-Rad Laboratories, Inc.Class A?

Bio-Rad Laboratories, Inc.Class A trades under the ticker BIO-B. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Bio-Rad Laboratories, Inc.Class A stock going up?

BIO-B has changed by -0.02% over the last week, -0.02% over the last month, and +17.30% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Bio-Rad Laboratories, Inc.Class A?

Bio-Rad Laboratories, Inc.Class A currently has a market capitalization of 9.85 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Bio-Rad Laboratories, Inc.Class A earnings last quarter?

Last quarter, Bio-Rad Laboratories, Inc.Class A reported earnings of 17.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Bio-Rad Laboratories, Inc.Class A revenue for the last quarter?

Bio-Rad Laboratories, Inc.Class A reported quarterly revenue of 656.4 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Bio-Rad Laboratories, Inc.Class A net income for the last quarter?

Bio-Rad Laboratories, Inc.Class A reported net income of 458.6 M for the last quarter. The previous quarter showed 371.4 M, which means net income changed by +23.48%.

How many employees does Bio-Rad Laboratories, Inc.Class A have?

As of the latest available data, Bio-Rad Laboratories, Inc.Class A has 7 450 employees. Workforce size can provide additional context about the company's scale and operations.

What is Bio-Rad Laboratories, Inc.Class A EBITDA?

Bio-Rad Laboratories, Inc.Class A EBITDA is -20.4 M, and its EBITDA margin is -7.57%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Bio-Rad Laboratories, Inc.Class A stock?

You can buy Bio-Rad Laboratories, Inc.Class A (BIO-B) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Bio-Rad Laboratories, Inc.Class A stock?

Investing in Bio-Rad Laboratories, Inc.Class A requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BIO-B chart and related analysis on metatrader.com as part of your research.

Bio-Rad Laboratories Inc Class B

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.

News